Atopic dermatitis affects many in Singapore, yet severe cases remain difficult to control. New oral therapies like the JAK-1 inhibitor abrocitinib are expanding treatment options, with trials showing faster itch relief and improved skin clearance for some patients.
Log In or Register as a healthcare professional to read the full article.
